
Publication|Articles|May 8, 2025
- Advancing Screening for Chronic Kidney Disease: The Expanding Role of Pharmacists
Advancing Screening for Chronic Kidney Disease: The Expanding Role of Pharmacists
Advertisement
This program is made possible by an independent grant from Boehringer Ingleheim Pharmaceuticals, Inc. and Eli Lilly and Company.
This article summarizes collaborative strategies used by pharmacists to enhance chronic kidney disease screening, patient identification, and integration into diagnostic workflows, based on recommendations gleaned from roundtables of expert pharmacist stakeholders representing 23 different institutions.
View Issue
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
COVID-19 mRNA Vaccines May Boost Immunotherapy Response in Cancer
2
KEYNOTE Trial Data Presented at ESMO 2025 Congress Reiterate Pembrolizumab’s Benefits in NSCLC
3
Court Ruling Highlights Risks of Improper Dose Adjustments
4
Celebrating Pharmacists: Pharmacist Care Day in Pittsburgh
5















































































































































































































